← Evidence map

ReviewJournal of diabetes investigation2020

N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects.

Keizo KanasakiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31997585